Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 13, 2026 07:58 ET | Source: Research and Markets

Margenza (MacroGenics) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Margenza Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
April 13, 2026 07:44 ET | Source: Research and Markets

Zynyz (Incyte: retifanlimab-dlwr) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Zynyz Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
April 13, 2026 05:33 ET | Source: Research and Markets

Phage Therapies Market Research and Competitive Landscape Report 2026: Over 20 Companies and 22 Drugs by Product Type, Stage, Administration Route, and Molecule Type

Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Phage Therapies - Competitive Landscape, 2026" has been added to ResearchAndMarkets.com's offering. The report offers an extensive overview of...
March 25, 2026 12:15 ET | Source: Io Therapeutics, Inc.

Io Therapeutics, Inc. announces publication in Scientific Reports – Nature, of studies showing synergistic efficacy of its RXR agonist IRX4204 with the standard of care drug lenalidomide against multiple myeloma.

The Io Therapeutics, Inc. clinical stage anti-cancer RXR agonist compound demonstrated efficacy in models of human multiple myeloma.
March 13, 2026 12:37 ET | Source: Research and Markets

Roferon-a (F. Hoffmann-La Roche) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Roferon-a Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
March 13, 2026 12:31 ET | Source: Research and Markets

Rybrevant (Johnson & Johnson) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Rybrevant Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
March 13, 2026 07:41 ET | Source: Research and Markets

Ryzneuta (Evive Biotech, Acrotech Biopharma) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Ryzneuta Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
March 13, 2026 07:30 ET | Source: Research and Markets

Tecvayli (Johnson & Johnson) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Tecvayli Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
March 13, 2026 05:19 ET | Source: Research and Markets

Bayhep B (Bayer) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Bayhep B Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
March 12, 2026 12:26 ET | Source: Research and Markets

Pombiliti (Amicus Therapeutics) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, Forecasts

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Pombiliti Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...